<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003077'>Hyperlipidemia</z:hpo>, especially <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo> is one of the most important risk factors for <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Now it is well recognized that aggressive <z:chebi fb="23" ids="18059">lipid</z:chebi>-lowering drug treatment in high-risk individuals reduces <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> morbidity and mortality rates and increases overall survival </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0002155'>Hypertriglyceridemia</z:hpo> has now been recognized as another important risk factor for <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Recently, much attention has been focused on the atherogenesis of small, dense <z:chebi fb="15" ids="39026">LDL</z:chebi>, remnant <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> and isolated <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0002155'>Hypertriglyceridemia</z:hpo> is known to be deeply involved in the pathogenesis of <z:hpo ids='HP_0000001'>all</z:hpo> of these abnormal <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> profiles </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, treatment of <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> as well as <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo> must be fully discussed </plain></SENT>
<SENT sid="6" pm="."><plain>In this issue, I will talk about new insights into treatment of <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> by changing the life style and/or by various hypolipidemic drugs </plain></SENT>
</text></document>